Susceptibility of malignant plasma cells to HA-1(H) specific lysis suggests a role for the minor histocompatibility antigen HA-1 in the graft-versus-myeloma effect

Leukemia. 2004 Sep;18(9):1543-5. doi: 10.1038/sj.leu.2403445.

Authors

P A Holloway, N Kaldenhoven, M van Dijk, A C Bloem, W de Lau, R van der Zee, B Kircher-Eibl, T Mutis, H M Lokhorst

PMID: 15322561
DOI: 10.1038/sj.leu.2403445

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Disease Susceptibility
Graft vs Tumor Effect / physiology*
Humans
Minor Histocompatibility Antigens / analysis
Minor Histocompatibility Antigens / genetics*
Multiple Myeloma / immunology*
Multiple Myeloma / metabolism
Multiple Myeloma / therapy
Oligopeptides / analysis
Oligopeptides / genetics*
Plasma Cells / immunology*
Plasma Cells / metabolism
Plasma Cells / pathology
Stem Cell Transplantation*
T-Lymphocytes / immunology
T-Lymphocytes, Cytotoxic / immunology
Transplantation, Homologous
Tumor Cells, Cultured

Substances

HA-1 antigen
Minor Histocompatibility Antigens
Oligopeptides